Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: A randomized, controlled trial

Archives of Internal Medicine

Volumn 160, Issue 15, 2000, Pages 2343-2348

  Fitzmaurice, David A ^a   Hobbs, F D Richard ^a   Murray, Ellen T ^a   Holder, Roger L ^a   Allan, Teresa F ^a   Rose, Peter E ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b WARWICK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED THERAPY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE SYSTEM; HOSPITAL MANAGEMENT; HUMAN; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034726379     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.15.2343     Document Type: Article

References (25)

1. Lowe GDO. Anti-thrombotic treatment and atrial fibrillation. BMJ. 1992;305: 1445-1446.
2. Sweeney KG, Pereira-Gray D, Steele R, Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract. 1995;45:153-158.
3. Gustafsson C, Asplund K, Britton M, Norrving B, Olsson B, Marke LA. Cost effectiveness of primary prevention in atrial fibrillation: Swedish national perspective. BMJ. 1992;305:1457-1460.
4. Sandercock P, Bamford J, Dennis W, et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire Community Stroke Project). BMJ. 1992;305:1460-1465.
5. British Society for Haematology, British Committee for Standards in Haematology Haemostasis and Thrombosis Task Force. Audit of oral anticoagulant treatment. J Clin Pathol. 1993;46:1069-1070.
6. Taylor F, Ramsey M, Voke J, Cohen H. GPs not prepared for monitoring anticoagulation [letter]. BMJ. 1993;307:1493.
7. Sudlow CM, Rodgers H, Kenny RA, Thomson RG. Service provision and use of anticoagulants in atrial fibrillation. BMJ. 1995;311:558-561.
8. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ. 1997; 314:1529-1530.
9. Shakespeare J. Anticoagulation in patients with atrial fibrillation: GPs struggle to meet demand [letter]. BMJ. 1994;308:415.
10. Fitzmaurice DA, Hobbs FDR, Murray ET, Bradley CP, Holder R. Evaluation of computerised decision support for oral anticoagulation management in primary care. Br J Gen Pract. 1996;46:533-535.
11. Ryan P, Gilbert M, Rose PE. Computer control of anti-coagulant dose for therapeutic management. BMJ. 1989;299:1207-1209.
12. Hobbs FDR, Delaney BC, Fitzmaurice DA, et al. A review of near patient testing in primary care. Health Technol Assess. 1997;1(5):i-iv, 1-229.
13. Rink E, Hilton S, Szczepura A, et al. Impact of introducing near patient testing for standard investigations in general practice. BMJ. 1993;307.775-778.
14. Hobbs FDR. Near patient testing in primary care. BMJ. 1996;312:263-264.
15. Kapiotis S, Quehenberger P, Speiser W. Evaluation of the new method Coagu-check for the determination of the prothrombin time from capillary blood: comparison with thrombotest on KC-1. Thromb Res. 1995;77:563-567.
16. Sanders KJ, Lewis SM, Cooper S, England JM. An Evaluation of the Nycomed Thrombotrak Coagulation System. London, England: NHS Procurement Directorate; 1989.
17. Oberhardt BJ, Dermott SC, Taylor M, Alkadi ZY, Abruzzini AF, Gresaffi NJ. Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin Chem. 1991;37:520-526.
18. Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol. 1993;46:299-303.
19. van den Besselar AMPH. Recommended method for reporting therapeutic control of oral anticoagulant therapy. Thromb Haemost. 1990;63:316-317.
20. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993; 69:236-239.
21. Azar AJ, Deckers JW, Rosendaal FR, et al. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemost. 1994;72:347-351.
22. Hobbs FDR, Delaney BC, Carson A, Kenkre JE. A prospective controlled trial of computerized decision support for lipid management in primary care. Fam Pract. 1996;13:133-137.
23. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet. 1996;348:423-428.
24. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation. Ann Intern Med. 1993;118:511-520.
25. van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. Arch Intern Med. 1993;153:1557-1562.